Research Article
Transition Metal(II) Complexes with Cefotaxime-Derived Schiff Base: Synthesis, Characterization, and Antimicrobial Studies
Table 8
Minimum inhibitory concentration (MIC) (µg/mL) of the synthesized compounds.
| | Number | Compound | E. coli 13147 | E. coli 13529 | K. pneumoniae 1204 | K. pneumoniae 13420 | P. aeruginosa 1246 | P. aeruginosa 13202 | B. subtilis 12488 | S. aureus
MRSA 1263 | S. aureus 13209 |
| | 1 | L | — | 0.5 | — | — | — | — | | — | — | | 2 | NiL2(H2O)2 | — | 0.5 | 1 | — | — | — | — | — | 1 | | 3 | CuL2(H2O)2 | 0.0625 | 0.033 | 0.125 | 0.5 | — | — | 1 | 1 | 0.5 | | 4 | ZnL2(H2O)2 | 0.5 | 0.25 | 0.5 | 0.5 | 1 | — | 1 | 1 | 1 | | 5 | CoL2(H2O)2 | 1 | 0.25 | 1 | 0.5 | — | 1 | 1 | 1 | 1 | | DMSO-control | | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
|
|
